- Report
- November 2023
- 146 Pages
Global
From €2401EUR$2,499USD£2,065GBP
- Report
- November 2023
- 142 Pages
Global
From €2401EUR$2,499USD£2,065GBP
- Report
- March 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- February 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- March 2024
- 147 Pages
Global
From €2882EUR$2,999USD£2,478GBP
- Report
- November 2023
- 148 Pages
Global
From €2401EUR$2,499USD£2,065GBP
- Report
- February 2024
- 178 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- November 2023
- 179 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- February 2024
- 230 Pages
Global
From €3491EUR$3,633USD£3,002GBP
€4987EUR$5,190USD£4,288GBP
- Report
- February 2024
- 113 Pages
Global
From €4564EUR$4,750USD£3,924GBP
- Report
- May 2023
- 60 Pages
Global
From €4756EUR$4,950USD£4,090GBP
- Report
- October 2023
- 170 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- November 2023
- 178 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- October 2023
- 181 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- February 2024
- 120 Pages
Global
From €4564EUR$4,750USD£3,924GBP
- Report
- February 2024
- 175 Pages
Global
From €2402EUR$2,500USD£2,066GBP
- Report
- February 2024
- 115 Pages
Global
From €4564EUR$4,750USD£3,924GBP
- Report
- February 2024
- 110 Pages
Global
From €4564EUR$4,750USD£3,924GBP
- Report
- February 2024
- 110 Pages
Global
From €4564EUR$4,750USD£3,924GBP
The Neurological Disorder market is a subset of the Neurology field, which focuses on the diagnosis and treatment of disorders of the nervous system. This includes conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke. The market is composed of a variety of stakeholders, including pharmaceutical companies, medical device manufacturers, healthcare providers, and research institutions.
The market is driven by the increasing prevalence of neurological disorders, as well as advances in technology and treatments. Pharmaceutical companies are developing new drugs to treat neurological disorders, while medical device manufacturers are creating innovative products to improve patient care. Healthcare providers are also playing an important role in providing diagnosis and treatment services.
Some companies in the Neurological Disorder market include AbbVie, Biogen, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more